Clinical and morphological parallels of lung and kidney damage in COVID-19

This article reviews the available literature on the SARS-Cov-2 virus and its similarities with its predecessors. The mechanisms of infection due to the structure and epidemiology of the virus are described. Based on these data, the pathogenesis of COVID- 19 infection is described. Based on this, the authors suggest probable extrapulmonary target cells and target organs for the virus depending on their expression ofthe vector protein, APF-2. The article describes a classic clinical picture of the disease, possible complications of its course, and the extrapulmonary (cardiac, immunological, renal) manifestations ofthe infection. The authors traced and described the chain of knowledge about the involvement of the kidneys in the pathological process at COVID-19. Based on numerous studies, we are looking at the site of acute renal injury, coagulopathy, systemic inflammatory response in the spectrum of manifestations of COVID-19 relative to kidneys in patients with COVID-19, including those with hemodialysis. The article builds clinical-morphological associations between lung and kidney damage at COVID-19. We present new data on the pathomorphological manifestations of COVID-19 in the lungs, including own autopsy data. Specific
signs of the effects of the virus on alveolocytes and its cytopathic effect are highlighted and described. The article focuses on kidney signs of infection. The authors give new results of their own observations obtained during an autopsy of patients with COVID-19. Detailed morphological changes in kidney structures have been described, proving that the human kidney is a specific target for SARS-Cov-2 infection, and can also serve as a viral reservoir for the pathogen, playing a role in its subsequent persistence.

1. Huang С, WangX Li X. Clinical features of patients in­fected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395( 10223):497-506

2. KsiazekTG, Erdman D, Goldsmith CS. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348(20):1953-1966. doi: 10.1056/NEJMoa030781

3. Zaki AM, Van Boheemen S, Bestebroer TM. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012;367(19):1814-1820

4. WangC, HorbyPW, Hayden FG.Anovel coronavirus outbreak of global health concern. Lancet 2020;395(10223):470-473

5. Menachery VD, Yount BL, Debbink K. A SARS-like cluster of circulating bat coronaviruses shows potential for human emer­gence. Nat Med 2015;21(12):1508-1513

6. WanX Shang J, Graham R. Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long struc­tural studies of SARS. J Virol 2020;March:1 -9

7. XuX, Chen P, Wang J et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sc/2020;63(3):457- 460

8. Rothan HA, Byrareddy SN. The epidemiology and patho­genesis of coronavirus disease (COVID-19) outbreak. JAutoimmun 2020;February: 102433. doi: 10.1016/j.jaut.2020.102433

9. Zhou P, Yang XL, Wang XG et al. A pneumonia outbreak as­sociated with a new coronavirus of probable bat origin. Nature 2020 Mar;579:270-273

10. ZouX, Chen K, Zou J etal. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential riskofdifferent human organs vulnerable to 2019-nCoV infection. Front Med 2020, Epub ahead of print

11. Wang D, Hu В, Hu С etal. Clinical characteristics of 138 hos­pitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020. doi: 10.1001/jama. 2020.1585

12. GuoY-R, CaoQD, Hong Z-S etal. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Military Med Res 2020;7:11. doi: 10.1186/S40779-020-00240-0

13. Xu Z, Shi L, WangY Pathological findings of COVID-19 asso­ciated with acute respiratory distress syndrome. Lancet RespirMed 2020;2600(20):19-21. doi: 10.1016/S2213-2600(20)30076-X

14. Ruan Q, Yang K, Wang W. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med2020. http://www.ncbi.nlm.nih. gov/pubmed/32125452//

15. Wu C, Chen X, Cai Y Risk factors associated with acute respiratory distress syndrome and death in patients with corona­virus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020:1-10

16. Yang X, YuX Xu J. Clinical course and outcomes of criti­cally ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Re­spirMed 2020;2600(20):1 -7

17. Ukimura A, Satomi H, Ooi Y Myocarditis associated with influenza A H1N1 pdm2009. Influenza Res Treat 2012;2012:1-8

18. Rao S, Sasser W, Diaz F. Coronavirus associated fulmi­nant myocarditis successfully treated with intravenous immu­noglobulin and extracorporeal membrane oxygenation. Chest 2014;146(4):336A. doi: 10.1378/chest.1992018

19. Alhogbani T. Acute myocarditis associated with novel Middle East respiratory syndrome coronavirus. Ann Saudi Med 2016;36(1):78-80

20. Gilca R, de Serres G, Boulianne N. Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada. Influenza Other Respir Viruses 2011;5(4):247-255

21. Yu CM, Wong RSM, Wu EB. Cardiovascular complica­tions of severe acute respiratory syndrome. Postgrad Med J 2006;82(964):140-144

22. Chu KH, Tsang WK, Tang CS etal. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int 2005;67(2):698-705

23. Anti-2019-nCoV Volunteers, Li Z, Wu M et al. Cau­tion on kidney dysfunctions of 2019-nCoV patients. medRxiv 2020;2020.02.08.20021212

24. Guan W-J, Ni Z-X HuY Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020:1-13

25. Li Z, Wu M, Guo J etal. Caution on Kidney Dysfunctions of 2019-nCoV Patients. MedRvix 2020, Epub ahead of print

26. Cheng X Luo R, Wang К et al. Kidney impairment is as­sociated with in-hospital death of COVID-19 patients. medRxiv 2020;2020.02.18.20023242

27. Yao XH, Li TX He ZC et al. A pathological report of three COVID-19 cases by minimally invasive autopsies. Zhonghua Bing Li XueZaZhi 2020. doi: 10.3760/cma.j.cn112151-20200312-00193. 32172546

28. Ye M, Wysocki J, William J et al. Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin- converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol 2006; 17(11 ):3067-3075

29. Wang D, Hu В, Hu С et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-infected Pneu­

30. monia in Wuhan, China. JAMA 2020, Epub ahead of print

31. Li Z, Wu M, Yao J et al. Caution on Kidney Dysfunctions of COVID-19 Patients Anti-2019-nCoVVolunteers. medRxiv 2020.02.08.20021212; doi: 10.1101/2020.02.08.20021212

32. Xu S, Fu L, Fei Jet al. Acute kidney injury at early stage as a negative prognostic i ndicator of patients with COVID-19: a hospital - based retrospective analysis. medRxiv 2020.03.24.20042408; doi: 10.1101/2020.03.24.20042408

33. Wang LA, Li XA, Chen HC et al. Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China. American Journal ofNephrology. FreeAccess. doi: 10.1159/000507471

34. MaX Diao B, LvXet al. 2019 novel coronavirus disease in hemodialysis (HD) patients: report from one HD center in Wuhan, China. medRx/V2020;2020.02.24.20027201

35. Perico L, BenigniA, RemuzziG. Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade. Nephron 2020. doi: 10.1159/000507305

36. Chan JF,Yuan S, Кок KH et al. A familial cluster of pneu­monia associated with the 2019 novel coronavirus indicating person-toperson transmission: a study of a family cluster. Lancet 2020;395:514-523

37. Corman VM, Landt O, Kaiser M et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 2020;25. doi: 10.2807/1560-7917.ES.2020.25.3.2000045

38. Zhang H, Zhou P, WeiYetal. Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID- 19. AnnlnternMed 2020M20-0533. doi: 10.7326/M20-0533

39. YaoXH, LiTX He ZC et al. A Pathological Report of Three COVID-19 Cases by Minimal Invasive Autopsies. Zhonghua Bing L/XueZaZh/2020;49(5):411-417.doi: 10.3760/cma.j.cn112151- 20200312-00193

40. McGonagle D, O’Donnell JS, Sharif К et al. Immune mechanisms of pulmonary intravascular coagulopathy in COVID- 19 pneumonia. Lancet Rheumatol 2020; Published Online May7, 2020. doi: 10.1016/ S2665-9913(20)30121-1

41. Chu KH, Tsang WK, Tang CS et al. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int 2005;67(2):698-705. doi: 10.1111/j.1523-175 ,2005.67130.x

42. Chu KH, Tsang WK, Tang CS et al. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kid- neylnt 2005;67(2):698-705

43. Tisoncik JR, Korth MJ, Simmons CP etal. Into the eye of the cytokine storm. Microbiology and Molecular Biology Reviews. MicrobiolMolBiol Rev2012;76(1):16-32

44. Huang KJ, Su IJ, Theron M et al. An interferon- gamma-related cytokine storm in SARS patients. J Med Virol 2005;75(2):185-194

45. Perazella MA, Shirali AC. Nephrotoxicity of cancer im­munotherapies: past, present and future. J Am SocNephrol 2018;29(8):2039-2052

46. MoiceanAD, Popp AM, Sinescu I. Thymoglobulin-newap­proaches to optimal outcomes. JMed Life 2009;2(3):319-324

47. Diao B, Feng Z, Wang С et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) infection. medRx/V2020;2020.03.04.20031120

48. Xu D, Zhang H, Gong H et al. Identification of a Potential Mechanism of Acute Kidney Injury During the Covid-19 Out­break: A Study Based on Single-Cell Transcriptome Analysis. Preprints. 2020 Feb. Available from: https://www.preprints.org/ manuscript/202002.0331/v1

49. WanYj Shang J, Graham R et al. Receptor recognition by the novel coronavirus from wuhan: an analysis based on decade- long structural studies of SARS coronavirus. J Virol 2020;94(7). doi: 10.1128/JVI.00127-20

50. Diao B, Wang C, Wang R et al. Human Kidney is a Target for Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. medRxiv 2020.03.04.20031120. doi: 10.1101/2020.03.04.20031120